Skip to main content

Alexion Pharmaceuticals, Inc.

ALXNDelisted Jul 21, 2021
Industry
Pharmaceutical Preparations
SEC CIK
0000899866

Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 711 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.

Q2 2025 vs. Q1 2025

How the institutions holding Alexion Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of ALXN: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders01+1
Shares0193+193
Value$0$5.52K+$5.52K

New holders (1)

Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to ALXN in Q2 2025
InstitutionSharesValue% of portfolio
Accent Capital Management, LLC193$5.52K0.00%

Sold out (0)

Institutions that held Alexion Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

None.